Zkusit zdarma
Humacyte, Inc.

Humacyte, Inc.

HUMA
Cena:
$ 1.05
+0.03 (2.94%)
Valuace
70
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

8:00 20-05-2026

- Surgical Implant – Next Generation contract makes Symvess more easily accessible to 170 VA hospi...

Humacyte Q1 Earnings Call Highlights

Humacyte Q1 Earnings Call Highlights

10:09 13-05-2026

Humacyte NASDAQ: HUMA reported first-quarter 2026 Symvess sales of $0.5 million and outlined a serie...

Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates

Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates

9:35 13-05-2026

Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus E...

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

7:00 13-05-2026

- Appointed Jim Mercadante as Chief Commercial Officer and Dr. Todd Rasmussen as Chief Surgical Offi...

Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

8:00 12-05-2026

- Distinguished vascular surgeon brings decades of clinical experience, innovation, and leadership t...

Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why

Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why

19:01 08-05-2026

Humacyte, Inc. (HUMA) closed at $1.06 in the latest trading session, marking a -1.85% move from the ...

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

18:00 08-05-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr.,...

Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026

Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026

8:00 08-05-2026

DURHAM, N. C. , May 08, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage b...

Humacyte, Inc. (HUMA) Surpasses Market Returns: Some Facts Worth Knowing

Humacyte, Inc. (HUMA) Surpasses Market Returns: Some Facts Worth Knowing

19:01 30-04-2026

In the closing of the recent trading day, Humacyte, Inc. (HUMA) stood at $0.84, denoting a +2.66% mo...

Humacyte, Inc. (HUMA) Discusses Unmet Needs and Advances in Dialysis Access with ATEV for Hemodialysis Patients Transcript

Humacyte, Inc. (HUMA) Discusses Unmet Needs and Advances in Dialysis Access with ATEV for Hemodialysis Patients Transcript

17:21 28-04-2026

Humacyte, Inc. (HUMA) Discusses Unmet Needs and Advances in Dialysis Access with ATEV for Hemodialys...

Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026

Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026

8:00 27-04-2026

DURHAM, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage b...

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

22:03 24-04-2026

NEW YORK and NEW ORLEANS, April 24, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charl...

Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why

Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why

19:01 24-04-2026

In the most recent trading session, Humacyte, Inc. (HUMA) closed at $0.7, indicating a -1.14% shift ...

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®

8:00 24-04-2026

- Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius Medical Care - ...

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

8:00 22-04-2026

– Industry veteran with more than 25 years of experience will lead next phase of biotech company's...

Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair

Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair

8:00 21-04-2026

- The Ministry of Health has set a 180-working-day review period for the MAA -  - MAA process is on...

Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why

Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why

19:16 16-04-2026

Humacyte, Inc. (HUMA) reached $0.68 at the closing of the latest trading day, reflecting a -7.13% ch...

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

13:21 13-04-2026

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti,...

Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

15:50 09-04-2026

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob...

Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors

Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors

19:16 07-04-2026

In the latest trading session, Humacyte, Inc. (HUMA) closed at $0.61, marking a -6.63% move from the...

close

HUMACYTE ANNOUNCES NEW U.S. DEPARTMENT OF DEFENSE FUNDING FOR PROCUREMENT OF BIOENGINEERED BLOOD VESSELS

09-02-2026
DURHAM, N.C., FEB. 09, 2026 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

HUMACYTE ANNOUNCES HOSPITAL CHARGE DATA SHOWING HIGH EXPENSE OF PREVENTABLE EXTREMITY ARTERIAL INJURY COMPLICATIONS

08-01-2026
- DATA IS FROM COMPREHENSIVE REVIEW OF HOSPITAL CHARGES AND ALL-PAYER CLAIMS OVER FIVE YEARS -  - P...
Více zde

HUMACYTE ANNOUNCES PLANNED MARKETING AUTHORIZATION APPLICATION FOR SYMVESS® IN ISRAEL

05-01-2026
- EXPANSION PLANS ARE BASED ON REQUESTS FOR PRODUCT ACCESS RECEIVED FROM SURGEONS AND HOSPITALS IN I...
Více zde

HUMACYTE ANNOUNCES PUBLICATION OF LONG-TERM SAFETY AND EFFICACY RESULTS OF SYMVESS® IN EXTREMITY TRAUMA REPAIR

22-12-2025
- RESULTS PUBLISHED IN JOURNAL OF VASCULAR SURGERY CASES, INNOVATIONS AND TECHNIQUES (JVS-CIT) -  -...
Více zde

HUMACYTE ANNOUNCES CREDIT FACILITY OF UP TO $77.5 MILLION WITH AVENUE CAPITAL

16-12-2025
DURHAM, N.C., DEC. 16, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

HUMACYTE ANNOUNCES PRESENTATIONS AT VEITHSYMPOSIUM HIGHLIGHTING POSITIVE ACELLULAR TISSUE ENGINEERED VESSEL (ATEV™) CLINICAL RESULTS

20-11-2025
– POST-IMPLANTATION ANALYSIS OF ATEVS DEMONSTRATES PROGRESSIVE RECELLULARIZATION WITH HOST CELLS, ...
Více zde

HUMACYTE ANNOUNCES SIX PRESENTATIONS SCHEDULED FOR THE UPCOMING 52ND ANNUAL SYMPOSIUM ON VASCULAR AND ENDOVASCULAR ISSUES, TECHNIQUES AND HORIZONS (VEITHSYMPOSIUM)

13-11-2025
DURHAM, N.C., NOV. 13, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

HUMACYTE ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

12-11-2025
- TOTAL REVENUES OF $753,000 FOR THIRD QUARTER, AND $1,571,000 FOR FIRST NINE MONTHS OF 2025, FROM S...
Více zde

HUMACYTE ANNOUNCES PRESENTATION OF POSITIVE TWO-YEAR RESULTS FROM PHASE 3 DIALYSIS ACCESS TRIAL AT THE AMERICAN SOCIETY OF NEPHROLOGY'S KIDNEY WEEK 2025

10-11-2025
– THE ATEV™ WAS OBSERVED TO HAVE SUPERIOR DURATION OF USE OVER 24 MONTHS COMPARED TO AUTOGENOUS ...
Více zde

HUMACYTE TO PRESENT THIRD QUARTER FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON NOVEMBER 12, 2025

06-11-2025
DURHAM, N.C., NOV. 06, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A CLINICAL-STAGE BIOT...
Více zde

HUMACYTE ANNOUNCES PUBLICATION OF NEW DATA COMPARING SYMVESS™ TO AUTOLOGOUS VEIN IN EXTREMITY ARTERIAL TRAUMA

30-10-2025
- RESULTS PUBLISHED IN AAST'S TRAUMA SURGERY & ACUTE CARE OPEN JOURNAL - - STUDY COMPARED OUTCOMES O...
Více zde

HUMACYTE ANNOUNCES PRICING OF $60.0 MILLION OVERSUBSCRIBED REGISTERED DIRECT OFFERING

07-10-2025
DURHAM, N.C., OCT. 07, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

HUMACYTE ANNOUNCES PUBLICATION OF LONG-TERM RESULTS FOR UKRAINIAN PATIENTS TREATED IN REAL-WORLD COMBAT SETTING WITH SYMVESS™

06-10-2025
- RESULTS PUBLISHED IN OXFORD ACADEMIC'S MILITARY MEDICINE JOURNAL - - AFTER UP TO 18 MONTHS OF FOLL...
Více zde

HUMACYTE ANNOUNCES EXPANSION OF INTELLECTUAL PROPERTY FOR PIPELINE PRODUCTS WITH GRANTING OF NEW U.S. PATENT FOR BIOENGINEERED ESOPHAGUS

29-09-2025
– PATENT COVERS ESOPHAGUS PRODUCED USING HUMACYTE'S PROPRIETARY BIOENGINEERED REGENERATIVE TISSUE ...
Více zde

HUMACYTE ANNOUNCES PUBLICATION OF PRECLINICAL DATA ON USE OF THE CTEV AS A CORONARY ARTERY BYPASS GRAFT (CABG)

18-09-2025
- RESULTS WERE PUBLISHED IN JACC: BASIC TO TRANSLATIONAL SCIENCE - - PUBLICATION EVALUATED CORONARY ...
Více zde

HUMACYTE ANNOUNCES PUBLICATION OF OUTCOMES FOR PATIENTS WITH HOSPITAL-ACQUIRED VASCULAR COMPLICATIONS TREATED WITH SYMVESS™

15-09-2025
- RESULTS WERE PUBLISHED IN THE JOURNAL OF VASCULAR SURGERY - - PUBLICATION DESCRIBED TREATMENT OF P...
Více zde

HUMACYTE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

11-08-2025
- TOTAL REVENUES OF $301,000 FOR QUARTER, AND $818,000 FOR FIRST SIX MONTHS OF 2025, FROM SALES AND ...
Více zde

HUMACYTE TO PRESENT SECOND QUARTER FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE ON AUGUST 11, 2025

07-08-2025
DURHAM, N.C., AUG. 07, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A CLINICAL-STAGE BIOT...
Více zde

HUMACYTE ANNOUNCES FIRST SYMVESS™ SALE TO MILITARY TREATMENT FACILITY

23-07-2025
SALE FOLLOWS RECENT ELECTRONIC CATALOG (ECAT) LISTING APPROVAL BY U.S. DEFENSE LOGISTICS AGENCY SYMV...
Více zde

HUMACYTE ANNOUNCES SYMVESS™ ECAT APPROVAL FROM U.S. DEFENSE LOGISTICS AGENCY

08-07-2025
DURHAM, N.C., JULY 08, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

RESULTS FROM HUMACYTE'S V007 PIVOTAL PHASE 3 AV ACCESS STUDY HIGHLIGHTED BY PRESENTATION AT THE SOCIETY FOR VASCULAR SURGERY MEETING

09-06-2025
DURHAM, N.C., JUNE 09, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

HUMACYTE CLINICAL RESULTS IN HIGH-RISK DIALYSIS PATIENTS FROM V007 PIVOTAL PHASE 3

02-06-2025
DURHAM, N.C., JUNE 02, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

HUMACYTE TO PRESENT AT THE H.C. WAINWRIGHT 3RD ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ

19-05-2025
DURHAM, N.C., MAY 19, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE BI...
Více zde

HUMACYTE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

13-05-2025
- COMMENCED MARKET LAUNCH AND FIRST COMMERCIAL SALES OF SYMVESS™ (ACELLULAR TISSUE ENGINEERED VESS...
Více zde

HUMACYTE TO PRESENT FIRST QUARTER FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE ON MAY 13, 2025

09-05-2025
DURHAM, N.C., MAY 09, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A CLINICAL-STAGE BIOTE...
Více zde

HUMACYTE ANNOUNCES FOURTH QUARTER AND YEAR END 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

28-03-2025
- RECEIVED U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL OF SYMVESS™ (ACELLULAR TISSUE ENGINEER...
Více zde

HUMACYTE TO PRESENT FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE ON MARCH 28, 2025

26-03-2025
DURHAM, N.C., MARCH 26, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A CLINICAL-STAGE BIO...
Více zde

HUMACYTE, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

25-03-2025
DURHAM, N.C., MARCH 25, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE B...
Více zde

HUMACYTE, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

25-03-2025
DURHAM, N.C., MARCH 25, 2025 (GLOBE NEWSWIRE) -- HUMACYTE, INC. (NASDAQ: HUMA), A COMMERCIAL-STAGE B...
Více zde

HUMACYTE ANNOUNCES PUBLICATION OF THE BUDGET IMPACT MODEL (BIM) FOR SYMVESS™ (ACELLULAR TISSUE ENGINEERED VESSEL-TYOD) IN THE JOURNAL OF MEDICAL ECONOMICS

10-03-2025
– SYMVESS IS A FIRST-IN-CLASS BIOENGINEERED HUMAN TISSUE DESIGNED TO BE A UNIVERSALLY IMPLANTABLE ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-16 00:00:008-KStáhnout
2025-12-15 00:00:008-KStáhnout
2025-11-26 00:00:008-KStáhnout
2025-11-12 00:00:008-KStáhnout
2025-11-12 00:00:0010-QStáhnout
2025-10-07 01:00:008-KStáhnout
2025-10-07 00:00:008-KStáhnout
2025-09-18 01:00:008-KStáhnout
2025-09-18 00:00:008-KStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 01:00:0010-QStáhnout
2025-08-11 00:00:008-KStáhnout
2025-08-11 00:00:0010-QStáhnout
2025-06-11 01:00:008-KStáhnout
2025-06-11 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-04-18 01:00:008-KStáhnout
2025-04-18 00:00:008-KStáhnout
2025-03-31 01:00:0010-KStáhnout
2025-03-31 00:00:0010-KStáhnout
2025-03-28 00:00:008-KStáhnout
2025-03-27 23:00:008-KStáhnout
2025-03-27 00:00:008-KStáhnout
2025-03-26 23:00:008-KStáhnout
2025-03-26 00:00:008-KStáhnout
2025-03-25 23:00:008-KStáhnout
2025-03-25 00:00:008-KStáhnout
2025-03-24 23:00:008-KStáhnout
2024-12-20 00:00:008-KStáhnout
2024-12-19 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-08 00:00:008-KStáhnout
2024-11-08 00:00:0010-QStáhnout
2024-11-07 23:00:008-KStáhnout
2024-11-07 23:00:0010-QStáhnout
2024-10-28 00:00:008-KStáhnout
2024-10-27 23:00:008-KStáhnout
2024-10-07 01:00:008-KStáhnout
2024-10-07 00:00:008-KStáhnout
2024-09-25 01:00:008-KStáhnout
2024-09-25 00:00:008-KStáhnout
2024-08-13 01:00:008-KStáhnout
2024-08-13 01:00:0010-QStáhnout
2024-08-13 00:00:008-KStáhnout
2024-08-13 00:00:0010-QStáhnout
2024-07-31 01:00:008-KStáhnout
2024-07-31 00:00:008-KStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-05-13 01:00:0010-QStáhnout
2024-05-13 00:00:0010-QStáhnout
2024-05-10 01:00:008-KStáhnout
2024-05-10 00:00:008-KStáhnout
2024-03-28 00:00:0010-KStáhnout
2024-03-27 23:00:0010-KStáhnout
2024-03-22 00:00:008-KStáhnout
2024-03-21 23:00:008-KStáhnout
2024-03-04 00:00:008-KStáhnout
2024-03-03 23:00:008-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-28 23:00:008-KStáhnout
2024-02-09 00:00:008-KStáhnout
2024-02-08 23:00:008-KStáhnout
2023-12-12 00:00:008-KStáhnout
2023-12-11 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-09-12 01:00:008-KStáhnout
2023-09-12 00:00:008-KStáhnout
2023-08-14 01:00:008-KStáhnout
2023-08-14 01:00:0010-QStáhnout
2023-08-14 00:00:008-KStáhnout
2023-08-14 00:00:0010-QStáhnout
2023-07-26 01:00:008-KStáhnout
2023-07-26 00:00:008-KStáhnout
2023-06-08 01:00:008-KStáhnout
2023-06-08 00:00:008-KStáhnout
2023-05-12 01:00:008-KStáhnout
2023-05-12 01:00:0010-QStáhnout
2023-05-12 00:00:008-KStáhnout
2023-05-12 00:00:0010-QStáhnout
2023-03-24 00:00:008-KStáhnout
2023-03-24 00:00:0010-KStáhnout
2023-03-23 23:00:008-KStáhnout
2023-03-23 23:00:0010-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2022-12-12 00:00:008-KStáhnout
2022-12-11 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-09-20 01:00:008-KStáhnout
2022-09-20 00:00:008-KStáhnout
2022-08-12 01:00:008-KStáhnout
2022-08-12 01:00:0010-QStáhnout
2022-08-12 00:00:008-KStáhnout
2022-08-12 00:00:0010-QStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-05-13 01:00:008-KStáhnout
2022-05-13 01:00:0010-QStáhnout
2022-05-13 00:00:008-KStáhnout
2022-05-13 00:00:0010-QStáhnout
2022-03-29 01:00:008-KStáhnout
2022-03-29 01:00:0010-KStáhnout
2022-03-29 00:00:008-KStáhnout
2022-03-29 00:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-27 00:00:008-KStáhnout
2021-12-26 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-15 00:00:0010-QStáhnout
2021-11-14 23:00:008-KStáhnout
2021-11-14 23:00:0010-QStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-11 23:00:008-KStáhnout
2021-09-02 01:00:008-KStáhnout
2021-09-02 00:00:008-KStáhnout
2021-08-30 01:00:008-KStáhnout
2021-08-30 00:00:008-KStáhnout
2021-08-25 01:00:008-KStáhnout
2021-08-25 00:00:008-KStáhnout
2021-08-17 01:00:008-KStáhnout
2021-08-17 00:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:0010-QStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 00:00:008-KStáhnout
2021-06-07 01:00:008-KStáhnout
2021-06-07 00:00:008-KStáhnout
2021-05-26 01:00:008-KStáhnout
2021-05-26 00:00:008-KStáhnout
2021-05-21 01:00:008-KStáhnout
2021-05-21 00:00:008-KStáhnout
2021-05-20 01:00:008-KStáhnout
2021-05-20 00:00:008-KStáhnout
2021-05-17 01:00:0010-QStáhnout
2021-05-17 00:00:0010-QStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 00:00:008-KStáhnout
2021-04-21 01:00:008-KStáhnout
2021-04-21 00:00:008-KStáhnout
2021-04-14 01:00:008-KStáhnout
2021-04-14 00:00:008-KStáhnout
2021-03-05 00:00:008-KStáhnout
2021-03-04 23:00:008-KStáhnout
2021-02-17 00:00:008-KStáhnout
2021-02-16 23:00:008-KStáhnout
2021-02-16 00:00:0010-KStáhnout
2021-02-15 23:00:0010-KStáhnout
2020-11-13 00:00:0010-QStáhnout
2020-11-12 23:00:0010-QStáhnout
2020-11-06 00:00:008-KStáhnout
2020-11-05 23:00:008-KStáhnout
2020-09-28 01:00:008-KStáhnout
2020-09-28 00:00:008-KStáhnout
2020-09-22 01:00:008-KStáhnout
2020-09-22 00:00:008-KStáhnout
preloader